A Phase 2, Randomized, Double-Blind, does-finding, Parallel Group, Multi-Center Study to evaluate Efficacy and Safety of M118103 in Subjects with Prurigo nodularis.
Phase 2
Recruiting
- Conditions
- Prurigo nodularis
- Registration Number
- JPRN-jRCT2031210028
- Lead Sponsor
- ishiura Tomoyuki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Prurigo nodularis patients.
Exclusion Criteria
Patients who have skin symptoms that could effect on evaluation of effectiveness of investigational drug.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method